Related references
Note: Only part of the references are listed.Melanoma of unknown primary: New perspectives for an old story
Stergios Boussios et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)
A PIK3R2 Mutation in Familial Temporal Lobe Epilepsy as a Possible Pathogenic Variant
Yishu Wang et al.
FRONTIERS IN GENETICS (2021)
Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implications
Wei Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
miR-126 reduces trastuzumab resistance by targeting PIK3R2 and regulating AKT/mTOR pathway in breast cancer cells
Fu Rao et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
CAPN1 promotes malignant behavior and erlotinib resistance mediated by phosphorylation of c-Met and PIK3R2 via degrading PTPN1 in lung adenocarcinoma
Yichuan Chen et al.
THORACIC CANCER (2020)
Targeting the PI3K/AKT/mTOR Pathway in Hormone-Positive Breast Cancer
Sara E. Nunnery et al.
DRUGS (2020)
Cirsiliol Suppressed Epithelial to Mesenchymal Transition in B16F10 Malignant Melanoma Cells through Alteration of the PI3K/Akt/NF-κB Signaling Pathway
Priyanka Prasad et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Candidate tumor suppressor gene IRF6 is involved in human breast cancer pathogenesis via modulating PI3K-regulatory subunit PIK3R2 expression
Hong-Fa Xu et al.
CANCER MANAGEMENT AND RESEARCH (2019)
MicroRNA-3662 targets ZEB1 and attenuates the invasion of the highly aggressive melanoma cell line A375
Lin Zhu et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Ginkgo biloba Exocarp Extract Inhibits the Metastasis of B16-F10 Melanoma Involving PI3K/Akt/NF-κB/MMP-9 Signaling Pathway
Chenjie Cao et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2018)
Akt Signaling Pathway in Macrophage Activation and M1/M2 Polarization
Eleni Vergadi et al.
JOURNAL OF IMMUNOLOGY (2017)
KMT2A promotes melanoma cell growth by targeting hTERT signaling pathway
Changlin Zhang et al.
CELL DEATH & DISEASE (2017)
Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K/Akt/NF-κB pathway
Meiling Yu et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Potential therapeutic targets of epithelial mesenchymal transition in melanoma
Ross L. Pearlman et al.
CANCER LETTERS (2017)
MicroRNA-126 inhibits proliferation and metastasis by targeting pik3r2 in prostate cancer
Lei Song et al.
MOLECULAR MEDICINE REPORTS (2016)
Melanoma screening: A plan for improving early detection
Richard Shellenberger et al.
ANNALS OF MEDICINE (2016)
MicroRNA-126 Targeting PIK3R2 Inhibits NSCLC A549 Cell Proliferation, Migration, and Invasion by Regulation of PTEN/PI3K/AKT Pathway
Lei Song et al.
CLINICAL LUNG CANCER (2016)
microRNA-126 targeting PIK3R2 promotes rheumatoid arthritis synovial fibro-blasts proliferation and resistance to apoptosis by regulating PI3K/AKT pathway
Jie Gao et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2016)
The PI3K AKT pathway in the pathogenesis of prostate cancer
Xiaofei Wen
Frontiers in Bioscience-Landmark (2016)
MiR-30a-5p Overexpression May Overcome EGFR-Inhibitor Resistance through Regulating PI3K/AKT Signaling Pathway in Non-small Cell Lung Cancer Cell Lines
Fei Meng et al.
FRONTIERS IN GENETICS (2016)
AP-1/c-Jun transcription factors: Regulation and function in malignant melanoma
Melanie Kappelmann et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2014)
The melanoma revolution: From UV carcinogenesis to a new era in therapeutics
Jennifer A. Lo et al.
SCIENCE (2014)
Synthesis and SAR Studies of Dual AKT/NF-κB Inhibitors Against Melanoma
Elisa Barile et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2013)
Differential AKT dependency displayed by mouse models of BRAFV600E-initiated melanoma
Victoria Marsh Durban et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2
Ni Zhu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Class IPI3K in oncogenic cellular transformation
L. Zhao et al.
ONCOGENE (2008)
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Jeffrey A. Engelman et al.
NATURE REVIEWS GENETICS (2006)
High frequency of mutations of the PIK3CA gene in human cancers
Y Samuels et al.
SCIENCE (2004)
Share Paper
